Found 7 matching trials
A Clinical Study of Efinopegdutide in Participants With Precirrhotic Nonalcoholic Steatohepatitis (NASH) (MK-6024-013)
PHASE2The purpose of this study is to learn how well efinopegdutide works compare...
Location
The Institute for Liver Health II dba Arizona Clinical Trial-The Institute for Liver Health ( Site 3
A Study of Efinopegdutide in Participants With Hepatic Impairment (MK-6024-014)
PHASE1The purpose of this study was to evaluate the pharmacokinetics of efinopegd...
Location
Clinical Pharmacology of Miami ( Site 0005)
A Clinical Study of Efinopegdutide (MK-6024) in Healthy Chinese Volunteers (MK-6024-011)
PHASE1The goal of this study is to learn about the safety and whether people tole...
Location
Zhongshan Hospital,Fudan University-Dep. of Clinical Pharmacology (Site 0001)
A Study of Efinopegdutide in Healthy Obese Participants (MK-6024-015)
PHASE1The goal of this study is to learn about the safety of efinopegdutide (MK-6...
Location
QPS-MRA, LLC (Site 0001)
A Clinical Study of Efinopegdutide in People With Compensated Cirrhosis Due to Steatohepatitis (MK-6024-017)
PHASE2Researchers are looking for ways to treat a type of liver disease caused by...
Status
Active Not Recruiting
Location
The Institute for Liver Health II dba Arizona Clinical Trial-The Institute for Liver Health ( Site 0149)
Alternate Dosing Study of MK-6024 in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) (MK-6024-016)
PHASE2This study will evaluate the effect of efinopegdutide administration once e...
Location
The Institute for Liver Health II dba Arizona Clinical Trial-The Institute for Liver Health ( Site 0
A Study of Efinopegdutide (MK-6024) in Participants With Nonalcoholic Fatty Liver Disease (NAFLD) (MK-6024-001)
PHASE2The principal goal of this study is to determine the efficacy of efinopegdu...
Location
Catalina Research Institute, LLC ( Site 1939)